Revisiting Buruli ulcer, The Journal of Dermatology, vol.66, issue.11, 2015. ,
DOI : 10.1111/1346-8138.13049
Epidemiology and management of Buruli ulcer, Expert Review of Anti-infective Therapy, vol.12, issue.7, pp.855-865, 2014. ,
DOI : 10.1586/14787210.2014.910113
Risk of Buruli Ulcer and Detection of Mycobacterium ulcerans in Mosquitoes in Southeastern Australia, PLoS Neglected Tropical Diseases, vol.1, issue.9, p.1305, 2011. ,
DOI : 10.1371/journal.pntd.0001305.t002
Ecology and Transmission of Buruli Ulcer Disease: A Systematic Review, PLoS Neglected Tropical Diseases, vol.30, issue.1, p.911, 2010. ,
DOI : 10.1371/journal.pntd.0000911.s001
Buruli ulcer (Mycobacterium ulcerans infection), Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.102, issue.10, pp.969-978, 2008. ,
DOI : 10.1016/j.trstmh.2008.06.006
Buruli ulcer: emerging from obscurity, The Lancet, vol.367, issue.9525, pp.1849-1858, 2006. ,
DOI : 10.1016/S0140-6736(06)68807-7
Identification and characterization of IS2404 and IS2606: two distinct repeated sequences for detection of Mycobacterium ulcerans by PCR, J Clin Microbiol, vol.37, pp.1018-1023, 1999. ,
Efficacy of the Combination Rifampin-Streptomycin in Preventing Growth of Mycobacterium ulcerans in Early Lesions of Buruli Ulcer in Humans, Antimicrobial Agents and Chemotherapy, vol.49, issue.8, pp.3182-3186, 2005. ,
DOI : 10.1128/AAC.49.8.3182-3186.2005
Clinical Efficacy of Combination of Rifampin and Streptomycin for Treatment of Mycobacterium ulcerans Disease, Antimicrobial Agents and Chemotherapy, vol.54, issue.9, pp.3678-3685, 2010. ,
DOI : 10.1128/AAC.00299-10
Pathogenesis of skin ulcers: lessons from the Mycobacterium ulcerans and Leishmania spp. pathogens, Cellular and Molecular Life Sciences, vol.198, issue.13, 2014. ,
DOI : 10.1007/s00018-014-1561-z
URL : https://hal.archives-ouvertes.fr/pasteur-01387237
Mycolactone: A Polyketide Toxin from Mycobacterium ulcerans Required for Virulence, Science, vol.283, issue.5403, pp.854-857, 1999. ,
DOI : 10.1126/science.283.5403.854
Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans, Proceedings of the National Academy of Sciences, vol.101, issue.5, pp.1345-1349, 2004. ,
DOI : 10.1073/pnas.0305877101
Mycolactones: immunosuppressive and cytotoxic polyketides produced by aquatic mycobacteria, Natural Product Reports, vol.45, issue.3, pp.447-454, 2008. ,
DOI : 10.1039/b803101k
Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans, Nature Reviews Microbiology, vol.4, issue.1, pp.50-60, 2009. ,
DOI : 10.1093/molbev/msm092
Mycolactone Diffuses from Mycobacterium ulcerans???Infected Tissues and Targets Mononuclear Cells in Peripheral Blood and Lymphoid Organs, PLoS Neglected Tropical Diseases, vol.23, issue.10, p.325, 2008. ,
DOI : 10.1371/journal.pntd.0000325.g006
Mycolactone Diffuses into the Peripheral Blood of Buruli Ulcer Patients - Implications for Diagnosis and Disease Monitoring, PLoS Neglected Tropical Diseases, vol.9, issue.7, p.1237, 2011. ,
DOI : 10.1371/journal.pntd.0001237.t001
URL : https://hal.archives-ouvertes.fr/inserm-00691438
Mycolactone Suppresses T Cell Responsiveness by Altering Both Early Signaling and Posttranslational Events, The Journal of Immunology, vol.184, issue.3, pp.1436-1444, 2010. ,
DOI : 10.4049/jimmunol.0902854
URL : https://hal.archives-ouvertes.fr/pasteur-00594632
Shaping mycolactone for therapeutic use against inflammatory disorders, Science Translational Medicine, vol.7, issue.289, pp.289-285, 2015. ,
DOI : 10.1126/scitranslmed.aab0458
URL : https://hal.archives-ouvertes.fr/pasteur-01382767
Mycolactone impairs T cell homing by suppressing microRNA control of L-selectin expression, Proceedings of the National Academy of Sciences, vol.108, issue.31, pp.12833-12838, 2011. ,
DOI : 10.1073/pnas.1016496108
URL : https://hal.archives-ouvertes.fr/pasteur-00738806
Mycolactone Inhibits Monocyte Cytokine Production by a Posttranscriptional Mechanism, The Journal of Immunology, vol.182, issue.4, pp.2194-2202, 2009. ,
DOI : 10.4049/jimmunol.0802294
virulence factor mycolactone underlying the cell death and immunosuppression seen in Buruli ulcer, Biochemical Society Transactions, vol.11, issue.1, pp.177-183, 2014. ,
DOI : 10.1002/cbic.200400339
17693 | DOI: 10.1038/srep17693 22 The pathogenic mechanism of the Mycobacterium ulcerans virulence factor, mycolactone, depends on blockade of protein translocation into the ER, PLoS Pathog, vol.5, issue.10, p.1004061, 2014. ,
Combined Inflammatory and Metabolic Defects Reflected by Reduced Serum Protein Levels in Patients with Buruli Ulcer Disease, PLoS Neglected Tropical Diseases, vol.25, issue.4, p.2786, 2014. ,
DOI : 10.1371/journal.pntd.0002786.s001
URL : https://hal.archives-ouvertes.fr/pasteur-01384561
Development and Application of Two Multiplex Real-Time PCR Assays for the Detection of Mycobacterium ulcerans in Clinical and Environmental Samples, Applied and Environmental Microbiology, vol.73, issue.15, pp.4733-4740, 2007. ,
DOI : 10.1128/AEM.02971-06
Sensitivity of PCR Targeting the IS2404 Insertion Sequence of Mycobacterium ulcerans in an Assay Using Punch Biopsy Specimens for Diagnosis of Buruli Ulcer, Journal of Clinical Microbiology, vol.43, issue.8, pp.3650-3656, 2005. ,
DOI : 10.1128/JCM.43.8.3650-3656.2005
Highly sensitive, operationally simple, cost/time effective detection of the mycolactones from the human pathogen Mycobacterium ulcerans, Chemical Communications, vol.66, issue.9, pp.1410-1412, 2010. ,
DOI : 10.1039/b924896j
The Key Role of Anaplerosis and Cataplerosis for Citric Acid Cycle Function, Journal of Biological Chemistry, vol.277, issue.34, pp.30409-30412, 2002. ,
DOI : 10.1074/jbc.R200006200
Acylcarnitine profile analysis, Genetics in Medicine, vol.6, issue.2, pp.151-156, 2008. ,
DOI : 10.1097/GIM.0b013e3181614289
Acylcarnitines, Diabetes, vol.62, issue.1, pp.1-8, 2013. ,
DOI : 10.2337/db12-0466
Correction: Biomarkers of Inflammation, Immunosuppression and Stress with Active Disease Are Revealed by Metabolomic Profiling of Tuberculosis Patients, PLoS ONE, vol.7, issue.12, 2012. ,
DOI : 10.1371/annotation/b7f554bc-ad78-4745-9cd6-e14954d6a01d
Glutathione Homeostasis and Functions: Potential Targets for Medical Interventions, Journal of Amino Acids, vol.107, issue.13, p.736837, 2012. ,
DOI : 10.1128/MCB.01080-08
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation, Physiological Reviews, vol.89, issue.1, pp.147-191, 2009. ,
DOI : 10.1152/physrev.00010.2008
A New Way to Degrade Heme: THE MYCOBACTERIUM TUBERCULOSIS ENZYME MhuD CATALYZES HEME DEGRADATION WITHOUT GENERATING CO, Journal of Biological Chemistry, vol.288, issue.14, pp.10101-10109, 2013. ,
DOI : 10.1074/jbc.M112.448399
Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer, Genome Research, vol.17, issue.2, pp.192-200, 2007. ,
DOI : 10.1101/gr.5942807
Analysis of the metabolome of Anopheles gambiae mosquito after exposure to Mycobacterium ulcerans, Scientific Reports, vol.118, issue.1, p.9242, 2015. ,
DOI : 10.1172/JCI34189
Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting, PLoS ONE, vol.15, issue.11, p.13953, 2010. ,
DOI : 10.1371/journal.pone.0013953.s007